1-3 of 3
Ken-ichi Hanada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes

Daniel Abate-Daga, Ken-ichi Hanada, Jeremy L. Davis, James C. Yang, Steven A. Rosenberg, Richard A. Morgan
Journal: Blood
Blood (2013) 122 (8): 1399–1410.
https://doi.org/10.1182/blood-2013-04-495531
Published: 2013
Includes: Supplemental data
Journal Articles

Molecular identification of an MHC-independent ligand recognized by a human α/β T-cell receptor

Ken-ichi Hanada, Qiong J. Wang, Takashi Inozume, James C. Yang
Journal: Blood
Blood (2011) 117 (18): 4816–4825.
https://doi.org/10.1182/blood-2010-11-317743
Published: 2011
Journal Articles

Cd8+ T-Cells Specifically Cytotoxic to Renal Cell Carcinoma (RCC) Cells Can Be Isolated from Patients with Regressing Metastatic Kidney Cancer after Allogeneic Nonmyeloablative Hematopoietic Cell Transplantation (NMHCT).

Yoshiyuki Takahashi, MD, PhD, Othon Mena, MD, Ramaprasad Srinivasan, MD, PhD, Takehito Igarashi, MD, PhD, Andreas Lundqvist, PhD, Dante Suffredini, J. Philip McCoy, Jr, PhD, Ken-ichi Hanada, MD, PhD, Marston Linehan, MD, Richard Childs, MD
Journal: Blood
Blood (2004) 104 (11): 4984.
https://doi.org/10.1182/blood.V104.11.4984.4984
Published: 2004